Changli Du

471 total citations
8 papers, 421 citations indexed

About

Changli Du is a scholar working on Biomedical Engineering, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Changli Du has authored 8 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomedical Engineering, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Changli Du's work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Lanthanide and Transition Metal Complexes (2 papers). Changli Du is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Lanthanide and Transition Metal Complexes (2 papers). Changli Du collaborates with scholars based in China and United States. Changli Du's co-authors include Yueqing Gu, Shunan Wan, Lingling Shan, Samuel Achilefu, Junmei Tian, Jie Cao, Dawei Deng, Zhiyu Qian, Sisi Cui and Siwen Li and has published in prestigious journals such as Biomaterials, Cancer Research and Frontiers in Pharmacology.

In The Last Decade

Changli Du

8 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changli Du China 7 196 186 170 65 52 8 421
Shunan Wan China 6 199 1.0× 165 0.9× 173 1.0× 64 1.0× 55 1.1× 7 399
Ravi Prakash Shukla India 14 200 1.0× 255 1.4× 198 1.2× 89 1.4× 86 1.7× 39 613
Manfei Fu China 11 254 1.3× 276 1.5× 150 0.9× 70 1.1× 71 1.4× 16 652
Seulki Lee South Korea 9 193 1.0× 260 1.4× 185 1.1× 65 1.0× 78 1.5× 13 556
Chetan Nehate India 10 220 1.1× 139 0.7× 160 0.9× 81 1.2× 48 0.9× 10 457
Zhichun Shen China 9 244 1.2× 235 1.3× 250 1.5× 88 1.4× 47 0.9× 11 533
Sandeep Urandur India 13 156 0.8× 197 1.1× 151 0.9× 67 1.0× 71 1.4× 16 438
Tiantian Tan China 12 197 1.0× 268 1.4× 173 1.0× 39 0.6× 47 0.9× 18 550
Hussaini Syed Sha Qhattal United States 5 259 1.3× 260 1.4× 183 1.1× 46 0.7× 50 1.0× 5 558
Beom Suk Lee South Korea 14 272 1.4× 273 1.5× 246 1.4× 76 1.2× 56 1.1× 21 651

Countries citing papers authored by Changli Du

Since Specialization
Citations

This map shows the geographic impact of Changli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Du more than expected).

Fields of papers citing papers by Changli Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Du. The network helps show where Changli Du may publish in the future.

Co-authorship network of co-authors of Changli Du

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Du. A scholar is included among the top collaborators of Changli Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Du. Changli Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Du, Changli, et al.. (2022). Codonopsis pilosula Polysaccharide Improved Spleen Deficiency in Mice by Modulating Gut Microbiota and Energy Related Metabolisms. Frontiers in Pharmacology. 13. 862763–862763. 27 indexed citations
2.
Chen, Haiyan, Shunan Wan, Fenxia Zhu, et al.. (2014). A fast tumor‐targeting near‐infrared fluorescent probe based on bombesin analog for in vivo tumor imaging. Contrast Media & Molecular Imaging. 9(2). 122–134. 14 indexed citations
3.
Cao, Jie, Sisi Cui, Siwen Li, et al.. (2013). Targeted Cancer Therapy with a 2-Deoxyglucose–Based Adriamycin Complex. Cancer Research. 73(4). 1362–1373. 74 indexed citations
4.
Du, Changli, Dawei Deng, Lingling Shan, et al.. (2013). A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Biomaterials. 34(12). 3087–3097. 210 indexed citations
5.
Shan, Lingling, et al.. (2012). Synthesis of a Novel l-Methyl-Methionine–ICG-Der-02 Fluorescent Probe for In Vivo Near Infrared Imaging of Tumors. Molecular Imaging and Biology. 14(6). 699–707. 20 indexed citations
6.
Guo, Jing, Changli Du, Lingling Shan, et al.. (2012). Comparison of near‐infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo. Contrast Media & Molecular Imaging. 7(3). 289–301. 31 indexed citations
7.
Du, Changli, et al.. (2012). Synthesis and Evaluation of a Folate-linked Anti-cancer Prodrug. 106. 1089–1092. 1 indexed citations
8.
Shan, Lingling, Sisi Cui, Changli Du, et al.. (2011). A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. Biomaterials. 33(1). 146–162. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026